Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal Candidiasis

Inclusion Criteria: * Women of reproductive age who use effective contraceptive methods during the course of the study. * Clinical suspicion of vulvovaginal candidiasis, in the investigator's judgment, based on the presence of symptoms - e.g., pruritus, burning sensation, irritation, dyspareunia and/or abnormal vaginal discharge - and/or compatible clinical findings. * Possibility of collecting a vaginal sample at the baseline visit for microbiological analysis. * Ability and willingness to comply with the study procedures and to sign the informed consent form Exclusion Criteria: * Menstruation at the time of inclusion. * Pregnancy or breastfeeding. * Menopause or perimenopause. * Diabetes mellitus. * Presence of immunocompromised status or treatment with immunosuppressants within the 3 months prior to inclusion in the trial. * Vaginal coinfection in addition to vulvovaginal candidiasis. * Severe chronic diseases or other active infections that may interfere with the clinical assessment of vulvovaginal candidiasis, in the investigator's judgment. * History of intolerance or hypersensitivity to the intervention products. * Treatment with antifungals or probiotic supplements in the month prior to inclusion in the trial.